Guide9 min de lecture

Is it legal to import medicine for personal use?

A jurisdiction-by-jurisdiction summary of personal importation, written to help you check your own national rule rather than rely on hearsay.

By Health Affordability Editor4 cited sources

Points clés

  • 1Almost every country distinguishes commercial import from small personal-use quantities — and treats the latter more leniently, but 'tolerated' is not 'permitted'.
  • 2The three factors that consistently decide outcomes: a valid prescription, a quantity matching personal treatment, and whether the substance is controlled.
  • 3Controlled drugs (opioids, benzodiazepines, stimulants) follow separate, stricter rules — small quantities can still be criminal without authorisation.
  • 4Carry the prescription, a doctor's letter, original labelled packaging and a personal-use quantity to minimize customs problems.
Browse all 30 guides and case studies →
Sur cette page
  1. 1. The general principle
  2. 2. United States
  3. 3. United Kingdom and European Union
  4. 4. Documents that reduce the risk of a problem

1The general principle

Almost every country distinguishes between commercial importation, which is tightly licensed, and small quantities carried or shipped for a named individual's personal treatment. The second category is treated more leniently in many places — but 'more leniently' is not the same as 'permitted', and the rules are written narrowly.

Three factors consistently determine the outcome: whether you hold a valid prescription, whether the quantity is plausibly personal, and whether the specific substance is controlled.

2United States

The FDA's formal position is that importing unapproved medicines is generally not permitted, because products not approved for the US market fall outside its regulatory oversight. However, the agency publishes a personal importation policy describing circumstances in which it may exercise enforcement discretion.

Those circumstances typically involve a serious condition, no effective approved treatment available domestically, no commercialisation or promotion of the product to US residents, a quantity of roughly a personal course, and written confirmation that it is for the patient's own use under a named physician.

Enforcement discretion is exactly what the phrase says: discretion. Products may still be detained or destroyed at the border, and the policy does not create a right of import.

3United Kingdom and European Union

The UK permits individuals to bring in medicines for personal use, with quantity and documentation expectations, and applies separate rules for controlled drugs including a personal licence requirement above defined thresholds and durations.

The European Union does not operate a single harmonised personal-import rule. Each member state sets its own position, so what is acceptable in one country may be refused in another. Movement within the single market is treated differently from import from outside it.

Because of that variation, the only reliable step is to check your own national medicines agency and customs authority before ordering.

4Documents that reduce the risk of a problem

If you do import lawfully, carry or enclose the paperwork that demonstrates personal use.

  • A copy of the valid prescription in your name.
  • A signed letter from your prescriber stating the diagnosis, the medicine, the dose and the duration.
  • Medicines kept in original labelled packaging, not decanted into unlabelled containers.
  • A quantity that matches the stated treatment duration and no more.
  • A purchase invoice showing a non-commercial personal transaction.

Ce que montre le jeu de données Jivan

59×
écart moyen de prix
84%
des ancres dépassent 10×
344×
plus grand écart documenté

Across our full referenced dataset, 476 referenced molecules average a 59× price gap, 84% of them are at least 10× cheaper in India, and the widest documented comparison is Colchicine at 344×. Across the full referenced dataset the gap is systematic rather than anecdotal: 84% of anchored molecules are at least 10× cheaper, with a 59× average ratio — a market-structure effect repeated across all 26 therapy areas.

Explore this data in the catalog →

Calculé en direct à partir de 476 anchors

Questions fréquentes

There is no universal figure, but a supply matching your documented treatment duration — commonly up to about three months — is the usual expectation. Quantities beyond a plausible personal course invite treatment as commercial import.

Not necessarily, but they may. Enforcement varies by country, substance and shipment. Assume seizure is possible and never rely on an imported shipment as your only source of a critical medicine.

Often not. Many jurisdictions only recognise a prescription issued by a prescriber licensed in that country. Obtain a domestic prescription where possible.

Sources et lectures complémentaires

Chaque fait ci-dessus est traçable vers une source primaire publique. Nous citons les régulateurs et les organismes de santé publique, pas les vendeurs commerciaux.

  1. 1Personal Importation of MedicinesU.S. Food & Drug Administration
  2. 2Medicines and Healthcare products Regulatory AgencyUK Government
  3. 3Generic and Hybrid MedicinesEuropean Medicines Agency
  4. 4Travelling with MedicationsU.S. Centers for Disease Control and Prevention

Comment cet article a été rédigé

✔

Relu éditorialement

Editorial Review Board — Jivan

Sources checked against Tier-1/Tier-2 references.

Dernière révision 29 décembre 20254 sources citéesEditorial policy →Price methodology →

Avertissement médical important

Consultez toujours un médecin avant de changer de médicament, de dose ou de marque. Jivan fournit des informations éducatives et tarifaires et ne remplace ni un diagnostic ni les soins d'urgence.

Continuer la lecture

Help the admin